Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Roche Analyst Event on Diagnostics Division at AACC 2015 Dienstag, 30. Juni 2015 - 10:04

Roche - Investor Update

Basel, 30 June 2015
visual.jpg
We are pleased to invite you to an analyst event on Tuesday, 28 July 2015 to discuss Roche's Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Atlanta, Georgia (July 26-30, 2015). 
AACC brings together the global leaders in clinical chemistry, molecular diagnostics and lab management, and is the largest dedicated exhibition of equipment, instruments and services for clinical laboratories in the world.

The Analyst Event will start with an update on Roche Diagnostics HY 2015 results followed by a Q&A session on the Division and AACC highlights:
Venue: 
The Westin Peachtree Plaza
Meeting room: Chastain I (level 6)
210 Peachtree St NW
Atlanta, Georgia - 30303 
> map
Date/Time:
Tuesday, 28 July, 2015
5:30 pm EDT Registration desk opens
6:00 pm EDT Start of meeting
7:15 pm EDT End of meeting followed by a reception
> Download to my calendar
Presenter/Panellists:
Roland Diggelmann, Chief Operating Officer, Roche Diagnostics Division
Paul Brown, Head Roche Molecular Diagnostics
Jean-Claude Gottraux, Head Roche Professional Diagnostics
Jack Phillips, Head Roche Diagnostics North America
Dan Zabrowski, Head Roche Tissue Diagnostics and Sequencing Solutions

To register for the event, please follow the link (Password: Analyst2015)
Dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
+41 (0)58 310 50 00 (Europe and ROW) or
+44 (0)203 059 58 62 (UK) or
+1 (1)631 570 5613 (USA)

To expedite the registration process on the day of the conference call, you may pre-register for the event. > click here
Alternatively a live audio webcast can be accessed via http://ir.roche.com.
The presentation slides will be available from the IR website at http://ir.roche.com at the beginning of the event.
A replay of the conference call will be available following the event. Access is by dialing:

+41 (0) 91 612 4330 (Europe and ROW) or
+44 (0) 207 108 6233 (UK) or
+1 (1) 631 982 4566 (USA)

Please enter the conference ID 15307 followed by the # sign.
A replay of the webcast will be available on demand on the Roche website. > click here
Best regards, 
Dr. Karl Mahler
Head of Investor Relations
 
Dr. Birgit Masjost
Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber 
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com
 
Investor Relations North America
Dr. Stefan Foser 
Phone: +1 650 467-2016 
e-mail: foser.stefan@gene.com
Nina Goworek 
Phone: +1 650 467-8737 
e-mail: goworek.nina@gene.com
Ekaterine Kortkhonjia Ph.D. 
Phone: +1 650 467-5873 
e-mail: kortkhonjia.ekaterine@gene.com